A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer
<p>Abstract</p> <p>We report a case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy 6 years after primary treatment of triple-negative breast cancer. The primary tumor was negative for HER-2 as determined by im...
Main Authors: | Haruta Rumi, Masumoto Norio, Emi Akiko, Sasada Tatsunari, Kajitani Keiko, Kobayashi Yoshie, Kadoya Takayuki, Shigematsu Hideo, Kataoka Tsuyoshi, Oda Miyo, Arihiro Kouji, Okada Morihito |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/9/1/146 |
Similar Items
-
Trastuzumab – a monoclonal antibody – and dendrimers in a targeted therapy for breast cancer
by: Monika Marcinkowska, et al.
Published: (2015-01-01) -
Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis
by: Xinyi Li, et al.
Published: (2021-08-01) -
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
by: Sachin S Hingmire, et al.
Published: (2017-01-01) -
A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients
by: Erika Matos, et al.
Published: (2016-01-01) -
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population
by: Fan Yang, et al.
Published: (2020-03-01)